DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysisLinda M. Henricks, Jan H.M. Schellens, Didier Meulendijks et al.|The Lancet Oncology|2018Cited by 419
Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trialGeertjan van Tienhoven, Eva Versteijne, Casper H.J. van Eijck et al.|Trials|2016Cited by 156